Fully MHC-disparate mixed hemopoietic chimeras show specific defects in the control of chronic viral infections

Journal of Immunology

Volumn 179, Issue 4, 2007, Pages 2616-2626

  Koehn, Brent H ^a   Williams, Matthew A ^a,c   Borom, Keshawna ^a   Gangappa, Shivaprakash ^a   Pearson, Thomas C ^a   Ahmed, Rafi ^b   Larsen, Christian P ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CHIMERA; CONTROLLED STUDY; HAPLOTYPE; HEMATOPOIETIC SYSTEM; IMMUNOCOMPETENCE; IMMUNOTHERAPY; INFECTION CONTROL; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION; VIRUS REPLICATION; ADOPTIVE TRANSFER; ALLOTRANSPLANTATION; ANIMAL; B LYMPHOCYTE; BAGG ALBINO MOUSE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE MODEL; HEMATOPOIESIS; HISTOCOMPATIBILITY; IMMUNOLOGY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PATHOLOGY; TRANSPLANTATION TOLERANCE; VIROLOGY; VIRUS MENINGITIS;

ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HEMATOPOIESIS; HISTOCOMPATIBILITY ANTIGENS; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 34848815451     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.4.2616     Document Type: Article

References (60)

1. Fudaba, Y., T. R. Spitzer, J. Shaffer, T. Kawai, T. Fehr, F. Delmonico, F. Preffer, N. Tolkoff-Rubin, B. R. Dey, S. L. Saidman, et al. 2006. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am. J. Transplant. 6: 2121-2133.
2. Sykes, M. 2001. Mixed chimerism and transplant tolerance. Immunity 14: 417-424.
3. Kean, L. S., M. M. Durham, A. B. Adams, L. L. Hsu, J. R. Perry, D. Dillehay, T. C. Pearson, E. K. Waller, C. P. Larsen, and D. R. Archer. 2002. A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation. Blood 99: 1840-1849.
4. Adams, A. B., M. M. Durham, L. Kean, N. Shirasugi, J. Ha, M. A. Williams, P. A. Rees, M. C. Cheung, S. Mittelstaedt, A. W. Bingaman, et al. 2001. Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. J. Immunol. 167: 1103-1111.
5. Sykes, M., and D. H. Sachs. 2001. Mixed chimerism. Philos. Trans. R. Soc. London B Biol. Sci. 356: 707-726.
6. Singer, A., K. S. Hathcock, and R. J. Hodes. 1981. Self recognition in allogeneic radiation bone marrow chimeras: a radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells. J. Exp. Med. 153: 1286-1301.
7. Zinkernagel, R. M., A. Althage, G. Callahan, and R. M. Welsh, Jr. 1980. On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J. Immunol. 124: 2356-2365.
8. Ruedi, E., M. Sykes, S. T. Ildstad, C. H. Chester, A. Althage, H. Hengartner, D. H. Sachs, and R. M. Zinkernagel. 1989. Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2-P1) irradiation chimeras. Cell. Immunol. 121: 185-195.
9. Sharabi, Y., and D. H. Sachs. 1989. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J. Exp. Med. 169: 493-502.
10. Cobbold, S. P., G. Martin, S. Qin, and H. Waldmann. 1986. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323: 164-166.
11. Wekerle, T., J. Kurtz, H. Ito, J. V. Ronquillo, V. Dong, G. Zhao, J. Shaffer, M. H. Sayegh, and M. Sykes. 2000. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat. Med. 6: 464-469.
12. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434-438.
13. Durham, M. M., A. W. Bingaman, A. B. Adams, J. Ha, S.-Y. Waitze, T. C. Pearson, and C. P. Larsen. 2000. Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J. Immunol. 165: 1-4.
14. Tomita, Y., A. Khan, and M. Sykes. 1994. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J. Immunol. 153: 1087-1098.
15. Wekerle, T., M. H. Sayegh, J. Hill, Y. Zhao, A. Chandraker, K. G. Swenson, G. Zhao, and M. Sykes. 1998. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J. Exp. Med. 187: 2037-2044.
16. Ildstad, S. T., S. M. Wren, J. A. Bluestone, S. A. Barbieri, and D. H. Sachs. 1985. Characterization of mixed allogeneic chimeras: immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J. Exp. Med. 162: 231-244.
17. Morecki, S., B. Leshem, M. Weigensberg, S. Bar, and S. Slavin. 1985. Functional clonal deletion versus active suppression in transplantation tolerance induced by total-lymphoid irradiation. Transplantation 40: 201-210.
18. Williams, M. A., A. B. Adams, M. B. Walsh, N. Shirasugi, T. M. Onami, T. C. Pearson, R. Ahmed, and C. P. Larsen. 2003. Primary and secondary immunocompetence in mixed allogeneic chimeras. J. Immunol. 170: 2382-2389.
19. Martinic, M. M., T. Rulicke, A. Althage, B. Odermatt, M. Hochli, A. Lamarre, T. Dumrese, D. E. Speiser, D. Kyburz, H. Hengartner, and R. M. Zinkernagel. 2003. Efficient T cell repertoire selection in tetraparental chimeric mice independent of thymic epithelial MHC. Proc. Natl. Acad. Sci. USA 100: 1861-1866.
20. Van der Most, R. G., A. Sette, C. Oseroff, J. Alexander, K. Murali-Krishna, L. L. Lau, S. Southwood, J. Sidney, R. W. Chesnut, M. Matloubian, and R. Ahmed. 1996. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157: 5543-5554.
21. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205-2213.
22. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94: 6874-6879.
23. Brooks, D. G., L. Teyton, M. B. Oldstone, and D. B. McGavern. 2005. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 79: 10514-10527.
24. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68: 8056-8063.
25. Kalams, S. A., and B. D. Walker. 1998. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188: 2199-2204.
26. Matloubian, M., S. R. Kolhekar, T. Somasundaram, and R. Ahmed. 1993. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 67: 7340-7349.
27. Awadalla, Y., P. Randhawa, K. Ruppert, A. Zeevi, and R. J. Duquesnoy. 2004. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am. J. Transplant. 4: 1691-1696.
28. Bruce, D. S., K. A. Newell, M. A. Josephson, E. S. Woodle, J. B. Piper, J. M. Millis, D. S. Seaman, C. L. Carnrike, Jr., E. Huss, and J. R. Thistlethwaite, Jr. 1996. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation 62: 451-456.
29. Davis, C. L. 1990. The prevention of cytomegalovirus disease in renal transplantation. Am. J. Kidney Dis. 16: 175-188.
30. Hafiz, M. M., R. Poggioli, A. Caulfield, S. Messinger, M. C. Geiger, D. A. Baidal, T. Froud, J. V. Ferreira, A. G. Tzakis, C. Ricordi, and R. Alejandro. 2004. Cytomegalovirus prevalence and transmission after islet allograft transplant in patients with type 1 diabetes mellitus. Am. J. Transplant. 4: 1697-1702.
31. Hirsch, H. H., W. Knowles, M. Dickenmann, J. Passweg, T. Klimkait, M. J. Mihatsch, and J. Steiger. 2002. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N. Engl. J. Med. 347: 488-496.
32. Fischer, S. A., M. B. Graham, M. J. Kuehnert, C. N. Kotton, A. Srinivasan, F. M. Marty, J. A. Comer, J. Guarner, C. D. Paddock, D. L. DeMeo, et al. 2006. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354: 2235-2249.
33. Koehn, B., S. Gangappa, J. D. Miller, R. Ahmed, and C. P. Larsen. 2006. Patients, pathogens, and protective immunity: the relevance of virus-induced alloreactivity in transplantation. J. Immunol. 176: 2691-2696.
34. Strober, S., R. J. Lowsky, J. A. Shizuru, J. D. Scandling, and M. T. Millan. 2004. Approaches to transplantation tolerance in humans. Transplantation 77: 932-936.
35. Madsen, L., N. Labrecque, J. Engberg, A. Dierich, A. Svejgaard, C. Benoist, D. Mathis, and L. Fugger. 1999. Mice lacking all conventional MHC class II genes. Proc. Natl. Acad. Sci. USA 96: 10338-10343.
36. + T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur. J. Immunol. 29: 1243-1252.
37. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927.
38. Kean, L. S., K. Hamby, B. Koehn, E. Lee, S. Coley, L. Stempora, A. B. Adams, E. Heiss, T. C. Pearson, and C. P. Larsen. 2006. NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation. Am. J. Transplant. 6: 292-304.
39. Murali-Krishna, K., J. D. Altman, M. Suresh, D. Sourdive, A. Zajac, and R. Ahmed. 1998. In vivo dynamics of anti-viral CD8 T cell responses to different epitopes: an evaluation of bystander activation in primary and secondary responses to viral infection. Adv. Exp. Med. Biol. 452: 123-142.
40. Ahmed, R., A. Salmi, L. D. Butler, J. M. Chiller, and M. B. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160: 521-540.
41. Cook, E. B., J. L. Stahl, L. Lowe, R. Chen, E. Morgan, J. Wilson, R. Varro, A. Chan, F. M. Graziano, and N. P. Barney. 2001. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J. Immunol. Methods 254: 109-118.
42. Morgan, E., R. Varro, H. Sepulveda, J. A. Ember, J. Apgar, J. Wilson, L. Lowe, R. Chen, L. Shivraj, A. Agadir, et al. 2004. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. 110: 252-266.
43. Barber, D. L., E. J. Wherry, and R. Ahmed. 2003. Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 171: 27-31.
44. Zinkernagel, R. M., A. Althage, E. Waterfield, B. Kindred, R. M. Welsh, G. Callahan, and P. Pincetl. 1980. Restriction specificities, alloreactivity, and allotolerance expressed by T cells from nude mice reconstituted with H-2-compatible or -incompatible thymus grafts. J. Exp. Med. 151: 376-399.
45. Van der Most, R. G., K. Murali-Krishna, J. G. Lanier, E. J. Wherry, M. T. Puglielli, J. N. Blattman, A. Sette, and R. Ahmed. 2003. Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. Virology 315: 93-102.
46. Kagi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25: 3256-3262.
47. + T-cell response to readily eliminated and persistent viruses. Philos. Trans. R. Soc. London B Biol. Sci. 355: 1093-1101.
48. Stevens, T. L., A. Bossie, V. M. Sanders, R. Fernandez-Botran, R. L. Coffman, T. R. Mosmann, and E. S. Vitetta. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334: 255-258.
49. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
50. Colson, Y. L., R. A. Tripp, P. C. Doherty, S. M. Wren, M. Neipp, A. Y. Abou El-Ezz, and S. T. Ildstad. 1998. Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras: functional restriction to host MHC. J. Immunol. 160: 3790-3796.
51. Bevan, M. J., and P. J. Fink. 1978. The influence of thymus H-2 antigens on the specificity of maturing killer and helper cells. Immunol. Rev. 42: 3-19.
52. Starzl, T. E. 2004. Chimerism and tolerance in transplantation. Proc. Natl. Acad. Sci. USA 101 (Suppl. 2): 14607-14614.
53. Turner, S. J., P. C. Doherty, J. McCluskey, and J. Rossjohn. 2006. Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 6: 883-894.
54. Singer, A. 1988. Experimentation and thymic selection. J. Immunol. 140: 2481-2483.
55. Matzinger, P. 1993. Why positive selection? Immunol. Rev. 135: 81-117.
56. Nobori, S., E. Samelson-Jones, A. Shimizu, Y. Hisashi, S. Yamamoto, C. Kamano, K. Teranishi, P. A. Vagefi, M. Nuhn, M. Okumi, et al. 2006. Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine. Transplantation 81: 26-35.
57. Johnston, D. R., A. Muniappan, R. Hoerbelt, D. A. Guenther, T. Shoji, S. L. Houser, D. H. Sachs, and J. C. Madsen. 2005. Heart and en-bloc thymus transplantation in miniature swine. J. Thorac. Cardiovasc. Surg. 130: 554-559.
58. Klenerman, P., and A. Hill. 2005. T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 6: 873-879.
59. Babel, N., M. H. Hammer, and P. Reinke. 2003. [Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in chronic active Epstein-Barr infection.] Dtsch. Med. Wochenschr. 128: 548-550.
60. Savoldo, B., M. H. Huls, Z. Liu, T. Okamura, H. D. Volk, P. Reinke, R. Sabat, N. Babel, J. F. Jones, J. Webster-Cyriaque, et al. 2002. Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood 100: 4059-4066.